Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

Optimizing Decision-Making for CLL in an Era of Novel Agents

In science and medicine, information is constantly changing and may become out-of-date as new data emerge. All articles and interviews are informational only, should never be considered medical advice, and should never be acted on without review with your health care team.


Optimizing Decision-Making for CLL in an Era of Novel Agents

CLL Society has partnered with Clinical Care Options to develop an educational activity for healthcare providers who treat patients with CLL. This program features expert insight commentaries, an Interactive Treatment Decision Support Tool, and a series of micro education modules. Not only will this education help improve CLL care for healthcare providers, but it can also help empower and engage patients to become informed participants in shared decision-making. Have a look around in the CLL sections. Explore at your own pace. We hope some of this content looks familiar to you!


When appropriate, the CLL Society will be posting updates and background information on the present Coronavirus pandemic focusing on reliable primary sources of information and avoiding most of the news that is not directly from reliable medical experts or government and world health agencies.